APP and Alzheimer disease: This, together with the fact that the increase in astrocytic FABP7 expression is observed not only in the APP/PS1 mouse model but also in the brain of AD patients, supports the relevance and potential contribution of this observation to the neuroinflammatory environment observed in AD pathology.